CALCULATE YOUR SIP RETURNS

Stocks/Share Market - Angel One

Cupid Hits Upper Circuit – Net Profits surged by 283% in Q1FY25

Cupid Hits Upper Circuit – Net Profits surged by 283% in Q1FY25

7 August 2024

Introduction Cupid Limited, India’s premier manufacturer of male and female condoms, water-based lubricant jelly, IVD kits, and deodorants, has declared its financial results for the quarter ended June 30, 2024. The company has showcased remarkable growth across various financial metrics, reflecting its strategic initiatives and operational efficiency. Financial Highlights Rs in Lakhs Particulars Q1FY25 Q1FY24 …

NTPC to Raise Rs 12,000 Crore via NCDs

NTPC to Raise Rs 12,000 Crore via NCDs

7 August 2024

NTPC is India’s largest energy company, founded in 1975 to expedite power development in the country. Over the years, it has emerged as a leading player in the power sector, operating across the entire power generation value chain.  State-owned power giant NTPC will seek shareholder approval to raise up to Rs 12,000 crore through the …

L& T Finance Achieves NBFC-ICC Status from RBI

L& T Finance Achieves NBFC-ICC Status from RBI

7 August 2024

L&T Finance Ltd. has officially received its certificate of registration as a Non-Banking Financial Company (Investment and Credit Company) from the Reserve Bank of India (RBI) as of August 2. This transition marks a shift from its previous registration as an NBFC-Core Investment Company (NBFC-CIC), following the merger with its wholly owned subsidiaries, L&T Finance, …

Blue Star’s Q1 FY25 Revenue Surges 28.7% to ₹2,865.37 Crore

Blue Star’s Q1 FY25 Revenue Surges 28.7% to ₹2,865.37 Crore

7 August 2024

Blue Star Limited announced its financial results for Q1 FY 2025, reporting a 28.7% growth in consolidated revenue. The company’s Revenue from Operations rose significantly by 28.7% to ₹2,865.37 crore for the quarter ended June 30, 2024, compared to ₹2,226.00 crore during the same period in the previous year. The Operating Profit (EBITDA excluding Other …

Muthoot Capital Secured ₹100 Crore Impact Funding for Electric Vehicle Portfolio

Muthoot Capital Secured ₹100 Crore Impact Funding for Electric Vehicle Portfolio

6 August 2024

Muthoot Capital Services Limited (MCSL), a dynamic Non-Banking Finance Company (NBFC) and a cornerstone of the 137-year-old Muthoot Pappachan Group, is accelerating its commitment to sustainable mobility. The company has secured a significant ₹100 crore debt funding partnership with a UK-based Development Financial Institution (DFI), facilitated by Axis Bank. This investment will fuel MCSL’s electric …

Nazara Tech Subsidiary Absolute Sports Acquires DeltiasGaming.com for $900K

Nazara Tech Subsidiary Absolute Sports Acquires DeltiasGaming.com for $900K

6 August 2024

On August 06, 2024, Absolute Sports, a subsidiary of Nazara Technologies and the parent company of Sportskeeda.com, ProFootballNetwork.com, and SoapCentral.com, announced an agreement to purchase the assets of DeltiasGaming.com. DeltiasGaming.com is a leading source of gaming and esports content in the US. The deal, valued at $9,00,000 (~₹7.5 crore), will be paid in one or …

Diulcus® Approved for DFU in India: Ipca Partners with NovaLead

Diulcus® Approved for DFU in India: Ipca Partners with NovaLead

6 August 2024

On August 6, 2024, NovaLead’s patented repurposed drug was approved by CDSCO for treating Diabetic Foot Ulcer (DFU) in the Indian market. Ipca Laboratories Ltd will market the drug under the brand name Diulcus. The approval is based on a Phase III study showing that NovaLead’s patented drug, Diulcus®, helps close Diabetic Foot Ulcers (DFUs) …

Tata Elxsi and Skanray Partner to Advance Surgical Imaging Technology

Tata Elxsi and Skanray Partner to Advance Surgical Imaging Technology

6 August 2024

On August 6, 2024, Tata Elxsi Limited announced a strategic partnership with Skanray, a prominent global MedTech company specialising in diagnostic imaging, critical care, and surgical solutions. This collaboration is set to enhance surgical imaging core technology and software platform development, aiming to revolutionise diagnosis and treatment by incorporating advanced technology modules for greater predictability, …

Aurobindo Pharma Facility Receives US FDA’s ‘Official Action Indicated’ Classification

Aurobindo Pharma Facility Receives US FDA’s ‘Official Action Indicated’ Classification

6 August 2024

Aurobindo Pharma Ltd. announced that the US Food and Drug Administration (FDA) has classified its Unit II formulation manufacturing facility, operated by Eugia Pharma Specialities, as ‘Official Action Indicated’ (OAI) following an inspection. The inspection took place from April 25 to May 3, 2024, at the Bhiwadi facility in Alwar, Rajasthan. Implications of OAI Classification …

Symphony Approves Share Buyback at Over 100% Premium – Hits Upper Circuit

Symphony Approves Share Buyback at Over 100% Premium – Hits Upper Circuit

6 August 2024

Symphony Ltd., a leading manufacturer of consumer durables, announced a significant buyback of equity shares along with its June quarter results on Tuesday. The company has approved the repurchase of 2.85 lakh equity shares, constituting 0.41% of its total equity. Each share carries a face value of Rs 2. Share Buyback Details Symphony has set …

Open Free Demat Account!

Join our 3 Cr+ happy customers

+91
Open Free Demat Account!
Join our 3 Cr+ happy customers